One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis-Reference-Cited by-同舟云学术

One-year investigator-blind randomized multicenter trial comparing asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis

Published:2012-10 Issue:10 Volume:18 Page:1885-1893
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Hawthorne Barney A.,Stenson Rachel,Gillespie David,Swarbrick Edwin T.,Dhar Anjan,Kapur Kapil C.,Hood Kerry,Probert Chris S.J.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference31 articles.

1. Risk factors for non-adherence to medication in inflammatory bowel disease patients

2. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease

3. Once versus divided daily dosing with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

4. Studies on the mechanism of bowel disturbance in ulcerative colitis

5. Gastrointestinal Motility in Patients with Ulcerative Colitis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review;The Lancet Gastroenterology & Hepatology;2023-12

2. Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus;Journal of Clinical Medicine;2023-11-04

3. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems;Nature Reviews Drug Discovery;2023-03-27

4. Researching Interventions to Improve Medication Adherence in Ulcerative Colitis Patients;Journal of Coloproctology;2021-03

5. Clinical and Mechanistic Characteristics of Current JAK Inhibitors in IBD;Inflammatory Bowel Diseases;2020-12-09